WallStreetZenWallStreetZen

NASDAQ: PCRX
Pacira Biosciences Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Pacira Biosciences earnings were $5.1M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest PCRX earnings report on Mar 31, 2026 announced Q1 2026 earnings of $2.9M, up 78.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PCRX reported annual earnings of $7.0M, with -107.1% growth. The next PCRX earnings date is Aug 4, 2026.

PCRX past earnings growth

How has PCRX's earnings growth performed historically?

Company
N/A
Industry
18.8%
Market
89.73%
PCRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PCRX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PCRX earnings history

Current Revenue
$734.9M
Current Earnings
$5.1M
Current Profit Margin
0.7%

PCRX Return on Equity

Current Company
0.7%
Current Industry
12%
Current Market
13.5%
PCRX's Return on Equity (0.7%)... subscribe to Premium to read more.
High Return on Equity Performance

PCRX Return on Assets

Current Company
0.4%
Current Industry
5.1%
PCRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PCRX announces earnings.

PCRX Return on Capital Employed

Current Company
2.7%
Current Industry
11.4%
PCRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PCRX vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PCRX$120.92M$5.14M-48.83%$0.12
AMPH$193.05M$79.23M+95.42%$1.71
ETON$6.24M-$1.48MN/A-$0.05
EVON/A-$228.09MN/A-$0.64
ESPR$79.50M-$7.42MN/A$0.00
View Top Pharmaceutical Stocks

PCRX earnings dates

Next earnings date
Aug 4, 2026

Pacira Biosciences Earnings Reports & History FAQ

What were Pacira Biosciences's earnings last quarter?

On PCRX's earnings call on Invalid Date, Pacira Biosciences (NASDAQ: PCRX) reported Q1 2026 earnings per share (EPS) of $0.07, up 30% year over year. Total PCRX earnings for the quarter were $2.92 million. In the same quarter last year, Pacira Biosciences's earnings per share (EPS) was $0.10.

If you're new to stock investing, here's how to buy Pacira Biosciences stock.

When does Pacira Biosciences report earnings?

The next PCRX earnings call is Invalid Date. Add PCRX to your watchlist to be reminded of Pacira Biosciences's next earnings date.

Is Pacira Biosciences profitable or losing money?

As of the last Pacira Biosciences earnings report, Pacira Biosciences is currently profitable. Pacira Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $5.14 million, a 104.95% decrease year over year.

What was PCRX's earnings growth in the past year?

As of Pacira Biosciences's earnings date in Invalid Date, Pacira Biosciences's earnings has grown year over year. PCRX earnings in the past year totalled $5.14 million.

What are Pacira Biosciences's earnings expectations?

The current EPS estimate for Pacira Biosciences's earnings report in Invalid Date is $0.65.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.